Operating
Net Income
Pfizer Net Income decreased by 24.1% to $2.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.3%, from $2.97B to $2.70B. Over 2 years (FY 2021 to FY 2024), Net Income shows a downward trend with a -39.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase indicates higher profitability and operational success, while a decrease may signal rising costs or declining sales.
Detailed definition
Net income represents the total profit of the company after all operating expenses, taxes, and interest have been deduct...
Peer comparison
Standard across all public companies, though margins vary significantly by industry sector.
Metric ID:
net_income_cfHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.59B | $8.16B | $3.39B | $7.87B | $9.91B | $8.62B | $5.00B | $5.56B | $2.34B | -$2.38B | $3.12B | $48.00M | $4.47B | $418.00M | $2.97B | $2.93B | $3.55B | $2.70B |
| QoQ Change | — | +46.0% | -58.4% | +132.0% | +25.9% | -13.0% | -42.0% | +11.1% | -57.9% | -201.6% | +231.4% | -98.5% | >999% | -90.7% | +611.2% | -1.5% | +21.2% | -24.1% |
| YoY Change | — | — | — | — | +77.3% | +5.7% | +47.5% | -29.4% | -76.4% | -127.6% | -43.8% | -97.9% | +288.3% | — | -4.8% | >999% | -20.6% | -9.3% |
Range-$2.38B – $9.91B
CAGR-15.8%
Avg YoY Growth+462.2%
Median YoY Growth-9.3%
Net Income at Other Companies
Frequently Asked Questions
- What is Pfizer's net income?
- Pfizer (PFE) reported net income of $2.70B in Q1 2026.
- How has Pfizer's net income changed year-over-year?
- Pfizer's net income decreased by 9.3% year-over-year, from $2.97B to $2.70B.
- What is the long-term trend for Pfizer's net income?
- Over 2 years (2021 to 2024), Pfizer's net income has grown at a -39.5% compound annual growth rate (CAGR), from $22.03B to $8.06B.
- What does net income mean?
- The total profit a company earns after all expenses and taxes are paid.